Evidence method
Sequential · gp.financial.deposits
7.92% · CORE · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
WTBA · Dec 31, 2023
WEST BANCORPORATION INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001166928-24-000024Bank
Evidence method
Yoy · gp.fundamentals.net_income
-47.98% · CORE · VALID
Evidence method
Yoy · gp.financial.interest_expense
188.76% · CORE · VALID
Evidence method
Yoy · gp.financial.interest_income
29.96% · CORE · VALID
Evidence method
Level · gp.fundamentals.cash
$65.4M · CORE · VALID
Evidence method
Sequential · gp.financial.loans
2.75% · CORE · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History61 statesSelf-history eligible
Dec 31, 20215/5 normalizedLevel 3Mar 31, 20226/6 normalizedLevel 3Jun 30, 20226/6 normalizedLevel 3Sep 30, 20226/6 normalizedLevel 3Dec 31, 20226/6 normalizedLevel 3Mar 31, 20236/6 normalizedLevel 3Jun 30, 20236/6 normalizedLevel 3Sep 30, 20236/6 normalizedLevel 3Dec 31, 20236/6 normalizedLevel 3Dec 31, 20236/6 normalizedAmended as filedMar 31, 20246/6 normalizedLevel 3Jun 30, 20246/6 normalizedLevel 3Sep 30, 20245/5 normalizedLevel 3Dec 31, 20244/4 normalizedLevel 3Mar 31, 20254/4 normalizedLevel 3Jun 30, 20254/4 normalizedLevel 3Sep 30, 20254/4 normalizedLevel 3Dec 31, 20254/4 normalizedLevel 3Mar 31, 20264/4 normalizedLevel 3Jun 30, 20264/4 normalizedLevel 4
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.